Predicting brain tumor growth and treatment response using imaging techniques
Imaging-based tumor forecasting to predict brain tumor progression and response to therapy
This study is working on new ways to predict how glioblastoma brain tumors grow and respond to treatments, using personalized imaging data to create better treatment plans just for you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10895438 on NIH RePORTER |
What this research studies
This research aims to develop advanced methods for forecasting the progression of glioblastoma multiforme, a type of brain tumor, and how it responds to standard therapies. By utilizing subject-specific imaging data, the study will create biologically-based mathematical models that account for individual tumor characteristics and treatment regimens. This approach seeks to overcome the limitations of current imaging methods, which often fail to accurately predict patient outcomes. The goal is to provide a more personalized treatment plan for patients with brain tumors, enhancing their care and management.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with glioblastoma multiforme who are undergoing standard-of-care therapies.
Not a fit: Patients with brain tumors other than glioblastoma multiforme may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate predictions of tumor behavior and treatment responses, ultimately improving patient outcomes.
How similar studies have performed: Previous studies have shown promise in predictive modeling for brain tumors, but this approach aims to provide a more systematic and validated tool for clinical use.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Quarles, Christopher Chad — University of Tx Md Anderson Can Ctr
- Study coordinator: Quarles, Christopher Chad
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.